PREDNOD, a prediction server for peptide binding to the H-2g7 haplotype of the non-obese diabetic mouse

Autoimmunity

Volumn 39, Issue 8, 2006, Pages 645-650

  Rajapakse, Menaka ^a,b   Zhang, Guang Lan ^a,b   Srinivasan, Kellathur N ^c   Schmidt, Bertil ^b   Petrovsky, Nikolai ^d   Brusic, Vladimir ^e  

^a INSTITUTE FOR INFOCOMM RESEARCH   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c Johns Hopkins Singapore   (Singapore)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Autoimmune diabetes; I Ag7 haplotype; NOD; Type 1 diabetes

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; H2 ANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; CLIENT SERVER APPLICATION; CONTROLLED STUDY; EXPERIMENTAL MOUSE; HAPLOTYPE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; PEPTIDE ANALYSIS; PREDICTION; PROTEIN BINDING; ALGORITHM; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; COMPUTER PROGRAM; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; NONOBESE DIABETIC MOUSE; PREDICTION AND FORECASTING;

ALGORITHMS; AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; H-2 ANTIGENS; HAPLOTYPES; MICE; MICE, INBRED NOD; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; SOFTWARE;

EID: 33845689907     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930601062494     Document Type: Article

References (50)

1. Cresswell, P and Ackerman, AL and Giodini, A and Peaper, DR and Wearsch, PA. (2005) Mechanisms of MHC class I-restricted antigen processing and cross-presentation Immunol Rev, 207, pp. 145-157.
2. Li, P and Gregg, JL and Wang, N and Zhou, D and O'Donnell, P and Blum, JS and Crotzer, VL. (2005) Compartmentalization of class II antigen presentation: Contribution of cytoplasmic and endosomal processing Immunol Rev, 207, pp. 206-217.
3. Pamer, E and Cresswell, P. (1998) Mechanisms of MHC class I'restricted antigen processing Annu Rev Immunol, 16, pp. 323-358.
4. Villadangos, JA and Bryant, RA and Deussing, J and Driessen, C. (1999) Proteases involved in MHC class II antigen presentation Immunol Rev, 172, pp. 109-120.
5. Yewdell, JW and Bennink, JR. (2001) Cut and trim: Generating MHC class I peptide ligands Curr Opin Immunol, 13, pp. 13-18.
6. Bryant, P and Ploegh, H. (2004) Class II MHC peptide loading by the professionals Curr Opin Immunol, 16, pp. 96-102.
7. Zhong, W and Reche, PA and Lai, CC and Reinhold, B and Reinherz, EL. (2003) Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire J Biol Chem, 278, pp. 45135-45144.
8. Brusic, V and Zeleznikow, J. (1999) Computational binding assays of antigenic peptides Lett Pept Sci, 6, pp. 313-324.
9. Brusic, V and Bajic, VB and Petrovsky, N. (2004) Computational methods for prediction of T-cell epitopes - a framework for modelling, testing, and applications Methods, 34, pp. 436-443.
10. De Groot, AS and Saint-Aubin, C and Bosma, A and Sbai, H and Rayner, J and Martin, W. (2001) Rapid determination of HLA B*07 ligands from the west nile virus NY99 genome Emerg Infect Dis, 7, pp. 706-713.
11. Alyanakian, MA and You, S and Damotte, D and Gouarin, C and Esling, A and Garcia, C and Havouis, S and Chatenoud, L and Bach, JF. (2003) Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases Proc Natl Acad Sci USA, 100, pp. 15806-15811.
12. Aoki, CA and Borchers, AT and Ridgway, WM and Keen, CL and Ansari, AA and Gershwin, ME. (2005) Autoimmun Rev, 4, pp. 373-379.
13. Aly, T and Devendra, D and Eisenbarth, GS. (2005) Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes Am J Ther, 12, pp. 481-490.
14. Tisch, R and McDevitt, H. (1996) Insulin-dependent diabetes mellitus Cell, 85, pp. 291-297.
15. Stratmann, T and Apostolopoulos, V and Mallet-Designe, V and Corper, AL and Scott, CA and Wilson, IA and Kang, AS and Teyton, L. (2000) The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder Immunology, 165, pp. 3214-3225.
16. Rammensee, HG and Bachmann, J and Emmerich, NP and Bachor, OA and Stevanovic, S. (1999) SYFPEITHI: Database for MHC ligands and peptide motifs Immunogenetics, 50, pp. 213-219.
17. Reche, PA and Glutting, JP and Reinherz, EL. (2002) Prediction of MHC class I binding peptides using profile motifs Hum Immunol, 63, pp. 701-709.
18. Udaka, K and Wiesmuller, K and Kienle, S and Jung, G and Takamura, H and Yamagishi, H and Okumura, K and Walden, P and Suto, T and Kawasaki, T. (2000) An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries Immunogenetics, 51, pp. 816-828.
19. Zhang, G and Srinivasan, KN and Veeramani, A and August, T and Brusic, V. (2005) PREDBALB/C: A system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse Nucleic Acids Res, 33, pp. W180-W183.
20. Reich, EP and von Grafenstein, H and Barlow, A and Swenson, KE and Williams, K and Janeway, CA. (1994) Self peptides isolated from MHC glycoproteins of non-obese diabetic mice J Immunol, 152, pp. 2279-2288.
21. Amor, S and O'Neill, JK and Morris, MM and Smith, RM and Wraith, DC and Groome, N and Travers, PJ and Baker, D. (1996) Encephalitogenic epitopes of myelin basic protein, proteolipid proteing, and myelin oligodendrocyte glycoprotein for experimental allergic en-cephalomyelitis induction in Biozzi AB/H(H-2Ag7) mice share an amino acid motif Immunology, 156, pp. 3000-3008.
22. Reizis, B and Eisenstein, M and Bockova, J and Konene-Waisman, S and Mor, F and Elias, D and Cohen, IR. (1997) Molecular characterization of the diabetes mouse MHC class-II protein, I-Ag7 Int Immunol, 9, pp. 43-51.
23. Harrison, LC and Honeyman, MC and Trembleau, S and Gregori, S and Gallazzi, F and Augestein, P and Brusic, V and Hammer, J and Adorini, L. (1997) A peptide binding motif for I-Ag7, the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice J Exp Med, 185, pp. 1013-1021.
24. Latek, RR and Suri, A and Petzold, SJ and Nelson, CA and Kanagawa, O and Unanue, ER and Fremont, DH. (2000) Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice Immunity, 12, pp. 699-710.
25. Corper, AL and Stratmann, T and Apostolopoulos, V and Scott, CA and Garcia, KC and Kang, AS and Wilson, IA and Tevton, L. (2000) A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes Science, 288, pp. 505-511.
26. Gregori, S and Bono, E and Gallazzi, F and Hammer, J and Harrison, LC and Adorini, L. (2000) The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library Int Immunol, 12, pp. 493-503.
27. Rajapakse, M and Wyse, L and Schmidt, B and Brusic, V. (2005) Deriving matrix of peptide interactions in diabetic mouse by genetic algorithm Lect Notes Comp Sci, 3578, pp. 440-447.
28. Swets, JA. (1998) Measuring the accuracy of diagnostic systems Science, 240, pp. 1285-1293.
29. Yu, B and (2000) Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes J Immunol, 30, pp. 2497-2506.
30. Brusic, V and Rudy, G and Harrison, LC. (1994) MHCPEP, a database of MHC-binding peptides Nucleic Acids Res, 22, pp. 3663-3665.
31. Bhasin, M and Singh, H and Raghava, GP. (2003) MHCBN: A comprehensive database of MHC binding and non-binding peptides Bioinformatics, 19, pp. 665-666.
32. McSparron, H and Blythe, MJ and Zygouri, C and Doytchinova, IA and Flower, DR. (2004) JenPep: A novel computational information resource for immunobiology and vaccinology J Chem Inf Comput Sci, 43, pp. 1276-1287.
33. Rammensee, HG and Falk, K and Rotzschke, O. (1993) Peptides naturally presented by MHC class I molecules Annu Rev Immunol, 11, pp. 213-244.
34. Yu, K and Petrovsky, N and Schönbach, C and Koh, JYL and Brusic, V. (2002) Methods for prediction of peptide binding to MHC molecules: A comparative study Mol Med, 8, pp. 137-148.
35. Quesnel, A and Hsu, SC and Delmas, A and Steward, MW and Trudelle, Y and Abastado, JP. (1996) Efficient binding to the MHC class I K(d) molecule of synthetic peptides in which the anchoring position 2 does not fit the consensus motif FEBS Lett, 387, pp. 42-46.
36. Sette, A and Buus, S and Appella, E and Smith, JA and Chesnut, R and Miles, C and Colon, SM and Grey, HM. (1989) Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis Proc Natl Acad Sci USA, 86, pp. 3296-3300.
37. Mata, M and Travers, PJ and Liu, Q and Frankel, FR and Paterson, Y. (1998) The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D1 J Immunol, 161, pp. 2985-2993.
38. Saikh, KU and Martin, JD and Nishikawa, AH and Dillon, SB. (1995) Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/ Udorn/72 Virology, 214, pp. 445-452.
39. Zatechka, DS, Jr and Hegde, NR and Hariharan, K and Srikumaran, S. (1999) Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1 Vaccine, 17, pp. 686-694.
40. Pe'er, I and (2004) Proteomic signatures: Amino acid and oligopeptide compositions differentiate among phyla Proteins, 54, pp. 20-40.
41. Reche, PA and Glutting, JP and Reinherz, EL. (2002) Prediction of MHC class I binding peptides using profile motifs Hum Immunol, 63, pp. 701-709.
42. Reche, PA and Zhang, H and Glutting, JP and Reinherz, EL. (2005) EPIMHC: A curated database of MHC-binding peptides for customized computational vaccinology Bioinformatics, 21, pp. 2140-2141.
43. Lyman, M and Lee, H and Kang, B and Kang, H and Kim, B. (2002) Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles J Virol, 76, pp. 3125-3134.
44. Saren, A and Pascolo, S and Stevanovic, S and (2002) Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes Infect Immun, 70, pp. 3336-3343.
45. Sigal, L and Goebel, P and Wylie, D. (1995) Db-binding peptides from influenza virus: Effect of non-anchor residues on stability and immunodominance Mol Immunol, 32, pp. 623-632.
46. Hudrisier, D and Mazarguil, H and Laval, F and Oldstone, M and Gairin, J. (1996) Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues: Implications for peptide selection and presentation J Biol Chem, 271, pp. 17829-17836.
47. Blythe, MJ and Doytchinova, IA and Flower, DR. (2002) JenPep: A database of quantitative functional peptide data for immunology Bioinformatics, 18, pp. 434-439.
48. Gupta, V and Tabiin, TM and Sun, K and Chandrasekaran, A and Anwar, A and Yang, K and Chikhlikar, P and Salmon, J and Brusic, V and Marques, ET and Kellathur, SN and August, TJ. (2006) SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens Virology, 347, pp. 27-39.
49. Suri, A and Walters, JJ and Levisetti, MG and Gross, ML and Unanue, ER. (2006) Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells Eur J Immunol, 36(3), pp. 544-557.
50. Suri, A and (2002) In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket J Immunol, 168, pp. 1235-1243.